Skip to content

Xylosyl- and glucuronyltransferase LARGE2 (LARGE2)

Homo sapiens — UniProt Q8N3Y3

Gene: LARGE2Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Xylosyl- and glucuronyltransferase LARGE2 (LARGE2) is a protein from Homo sapiens identified by UniProt accession Q8N3Y3, 721 residues long. MolForge cross-references it against 0 known binders and 59 disease associations.

  • UniProt accession: Q8N3Y3; gene symbol LARGE2.
  • Organism: Homo sapiens.
  • Length: 721 amino acids.
  • Top disease associations (Open Targets): body height, cortical surface area measurement and risk-taking behaviour.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameXylosyl- and glucuronyltransferase LARGE2
UniProt accessionQ8N3Y3
GeneLARGE2
OrganismHomo sapiens
Length721 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (59)

Diseases linked to this target (Open Targets).

  • body height · score 0.31
  • cortical surface area measurement · score 0.12
  • risk-taking behaviour · score 0.12
  • SAPHO syndrome · score 0.10
  • brain measurement · score 0.09
  • age-related macular degeneration · score 0.08
  • antisocial behaviour measurement · score 0.08
  • attention deficit hyperactivity disorder · score 0.08
  • substance abuse · score 0.08
  • smoking status measurement · score 0.08

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8N3Y3-F1alphafoldPREDICTED87.28—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8N3Y3.

Amino-acid sequence (721 residues)

MLPRGRPRAL GAAALLLLLL LLGFLLFGGD LGCERREPGG RAGAPGCFPG PLMPRVPPDG RLRRAAALDG DPGAGPGDHN RSDCGPQPPP PPKCELLHVA IVCAGHNSSR DVITLVKSML FYRKNPLHLH LVTDAVARNI LETLFHTWMV PAVRVSFYHA DQLKPQVSWI PNKHYSGLYG LMKLVLPSAL PAELARVIVL DTDVTFASDI SELWALFAHF SDTQAIGLVE NQSDWYLGNL WKNHRPWPAL GRGFNTGVIL LRLDRLRQAG WEQMWRLTAR RELLSLPATS LADQDIFNAV IKEHPGLVQR LPCVWNVQLS DHTLAERCYS EASDLKVIHW NSPKKLRVKN KHVEFFRNFY LTFLEYDGNL LRRELFVCPS QPPPGAEQLQ QALAQLDEED PCFEFRQQQL TVHRVHVTFL PHEPPPPRPH DVTLVAQLSM DRLQMLEALC RHWPGPMSLA LYLTDAEAQQ FLHFVEASPV LAARQDVAYH VVYREGPLYP VNQLRNVALA QALTPYVFLS DIDFLPAYSL YDYLRASIEQ LGLGSRRKAA LVVPAFETLR YRFSFPHSKV ELLALLDAGT LYTFRYHEWP RGHAPTDYAR WREAQAPYRV QWAANYEPYV VVPRDCPRYD PRFVGFGWNK VAHIVELDAQ EYELLVLPEA FTIHLPHAPS LDISRFRSSP TYRDCLQALK DEFHQDLSRH HGAAALKYLP ALQQPQSPAR G

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with LARGE2?

The strongest Open Targets associations for LARGE2 are body height, cortical surface area measurement, risk-taking behaviour, SAPHO syndrome and brain measurement.

How long is the LARGE2 protein?

The Homo sapiens LARGE2 protein (UniProt Q8N3Y3) is 721 amino acids long.

Browse: Targets: L · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Xylosyl- and glucuronyltransferase LARGE2 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8N3Y3
GeneLARGE2
OrganismHomo sapiens
Length721
Binders0
Diseases59
View on UniProt